Mutational screening of breast cancer susceptibility gene 1 from early onset, bi-lateral, and familial breast cancer patients in Taiwan

Breast Cancer Research and Treatment

Volumn 77, Issue 2, 2003, Pages 133-143

  Chen, Shou Tung ^a   Chen, Ruei A ^b   Kuo, Shou Jen ^a   Chien, Yi Chih ^b  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b NATIONAL CHANGHUA UNIVERSITY OF EDUCATION   (Taiwan)

Author keywords

BRCA1; Haplotype; Mutations; PCR; Sequencing

Indexed keywords

DNA;

ADULT; ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA SEQUENCE; EXON; FAMILIAL CANCER; FEMALE; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SCREENING; HAPLOTYPE; HUMAN; HUMAN TISSUE; INTRON; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; ONCOGENE; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TAIWAN;

ADULT; AGE OF ONSET; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HAPLOTYPES; HUMANS; LOSS OF HETEROZYGOSITY; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; TAIWAN;

EID: 12244305151     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021386026051     Document Type: Article

References (47)

1. Miki Y, Swensen J, Sattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Brustow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66-71, 1994
2. Offit K, Gilewski T, McGuire P, Schluger A, Hampel H, Brown K, Swensen J, Neuhausen S, Skolnick M, Norton L, Goldgar D: Germline BRCA1 185delAG mutations in Jewish women with breast cancer. Lancet 347: 1643-1645, 1996
3. van der Looij M, Szabo C, Besznyak I, Liszka G, Csokay B, Pulay T, Toth J, Devilee P, King MC, Olah E: Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary. Int J Cancer 86: 737-740, 2000
4. van der Looij M, Wysocka B, Brozek I, Jassem J, Limon J, Olah E: Founder BRCA1 mutation and two novel germline BRCA2 mutation in breast and/or ovarian cancer families from north-eastern Poland. Hum Mutat 15: 480-481, 2000
5. Gorski B, Byrski T, Huzarski T, Jakubowska A, Menkiszak J, Gronwald J, Pluzańska A, Bebenek M, Fischer-Maliszewska L, Grzybowska E, Narod SA, Lubiński J: Founder mutation in the BRCA1 gene in Polish families with breast/ovarian cancer. Am J Hum Genet 66: 1963-1968, 2000
6. Liede A, Cohen B, Black DM, Davidson RH, Renwick A, Hoodfar E, Olopade OI, Micek M, Anderson V, De Mey R, Fordyce A, Warner E, Dann JL, King MC, Weber B, Narod SA, Steel CM: Evidence of a founder BRCA1 mutation in Scotland. Br J Cancer 82: 705-711, 2000
7. Andersen TL, Eiken HG, Couch F, Kaada G, Skrede M, Johnsen H, Aloysius TA, Tveit KM, Tranebjerg L, Dorum A, Moller P, Weber BL, Borresen-Dale A-L: Constant denaturant gel electrophoresis (CDGE) in BRCA1 mutation screening. Hum Mutat 11: 166-174, 1998
8. Markoff A, Sormbrine H, Bogdanova N, Preisler-Adams S, Ganev V, Dworniczak B, Horst J: Comparison of conformation-sensitive gel electrophoresis and single-strand conformation polymorphism analysis for detection of mutations in the BRCA1 gene using optimized conformation analysis protocols. Eur J Hum Genet 6: 145-150, 1998
9. Blesa JR, Hernandez-Yago J: Adaptation of conformation-sensitive gel electrophoresis to an ALFexpress™ DNA sequencer to screen BRCA1 mutations. BioTechniques 28: 1019-1025, 2000
10. Hogervorst FBL, Cornelius RS, Bout M, Van Vilet M, Oosterwijk JC, Olmer R, Bakker B, Klijn JGM, Vasen HFA, Devilee P, Ommen G-JB: Rapid detection of BRCA1 mutations by the protein truncation test Nat. Genet 10: 208-212, 1995
11. Plummer SJ, Anton-Culver H, Webster L, Noble B, Liao S, Kennedy A, Belinson J, Casey G: Detection of BRCA1 mutation by the protein truncation test. Hum Mol Genet 4: 1989-1991, 1995
12. Ho GH, Phang BH, Ng ISL, Law HY, Soo KC, Ng EH: Novel germline BRCA1 mutations detected in women in Singapore who developed breast carcinoma before the age of 36 years. Cancer 89: 811-816, 2000
13. Friedman LS, Ostermeyer A, Szabo CI, Dowd P, Lynch ED, Rowell SE, King MC: Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet 8: 399-404, 1994
14. Simard J, Tonin P, Durocher F, Morgan K, Rommens J, Gingras S, Samson C, Leblanc J-F, Belanger C, Dion F, Liu Q, Skolnick M, Goldgar D, Shattuck-Eidens D, Labrie F, Narod SA: Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat Genet 8: 392-398, 1994
15. Shattuck-Eidens D, McClure M, Simard J, Labrie F, Narod S, Couch F, Hoskins K, Weber B, Castilla L, Erdos M: A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. JAMA 273: 535-541, 1995
16. Cough FJ, Weber BL: the Breast Cancer Information Core (BIC), Mutations and polymorphisms in the families early onset breast cancer (BRCA1) gene Hum Mutat 8: 8-18, 1996
17. Couch FJ, DeShano ML, Blackwood MA, Calzone K, Stopfer J, Campeau L, Ganguly A, Rebbeck T, Weber BL: BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Eng J Med 336: 1409-1415, 1997
18. Krainer M, Silva-Arrieta S, FitzGerald MG, Shimada A, Ishioka C, Kanamaru R, MacDonald DJ, Unsal H, Finkelstein DM, Bowcock A, Isselbacher KJ, Haber DA: Differential contribution of BRCA1 and BRCA2 to early onset breast cancer. N Engl J Med 336: 1416-1421, 1997
19. Ramus SJ, Kote-Jarai Z, Friedman LS, van der Looij M, Gayther SA, Csokay B, Ponder BAJ, Olah E: Analysis of BRCA1 and BRCA2 mutations in hungarian families with breast or breast-ovarian cancer. Am J Hum Genet 60: 1242-1246, 1997
20. Serova OM, Mazoyer S, Puget N, Dubois V, Tonin P, Shugart YY, Goldgar D, Narod SA, Lynch HT, Lenoir GM: Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes? Am J Hum Genet 60: 486-495, 1997
21. Malone KE, Daling JR, Thompson JD, O'Brien CA, Francisco LV, Ostrander EA: BRCA1 mutations and breast cancer in the general population. JAMA 279: 922-929, 1998
22. Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, Easton DF, Evans C, Deacon J, Stratton MR: Prevalence of BRCA1 and BRCA2 gene mutation in patients with early onset breast cancer. J Natl Cancer Inst 91: 943-949, 1999
23. Inoue R, Fukutomi T, Tshijima T, Matsumoto Y, Sugimura T, Nagao M: Germline mutation of BRCA1 in Japanese breast cancer. Cancer Res 55: 3521-3524, 1995
24. Matsushima M, Kobayashi K, Emi M, Saito H, Saito J, Suzumori K, Nakamura Y: Mutations analysis of the BRCA1 gene in 76 Japanese ovarian cancer patients: four germline mutations, but no evidence of somatic mutation. Hum Mol Genet 4: 1953-1956, 1995
25. Katagiri T, Emi M, Ito I, Kobayashi K, Yoshimoto M, Iwase T, Kasumi F, Miki Y, Skolnick MH, Nakamura Y: Mutations in the BRCA1 genes in Japanese breast cancer patients. Hum Mutat 7: 334-339, 1996
26. Li SS-L, Tseng H-M, Yang T-P, Liu C-H, Teng S-J, Huang H-W, Chen L-M, Kao H-W, Chen J-H, Tseng J-N, Chen A, Hou M-F, Huang T-J, Chang H-T, Mok K-T, Tasi J-H: Molecular characterization of germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in Taiwan. Hum Genet 104: 201-204, 1999
27. Deng C-X, Brodie SG: Roles of BRCA1 and its interacting proteins. BioEssays 22: 738-737, 2000
28. Venkitaraman AR: Breast cancer genes and DNA repair. Science 286: 1100-1102, 1999
29. Scully RCJ, Ochs RL, Keegan K, Hoekstra M, Feunteun J, Livingston DM: Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 90: 425-436, 1997
30. Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, Haugen-Strano A, Swensen J, Miki Y, Eddington K, McClure M, Frye C, Weaver-Feldhaus J, Ding W, Gholami Z, Soderkvist P, Trry L, Jhanwar S, Berchuk A, Iglehart JD, Marks J, Ballinger DG, Barrett JC, Sholnick MH, Kamb A, Wiseman R: BRCA1 mutations in primary breast and ovarian carcinomas. Science 266: 120-122, 1994
31. Lasko D, Cavenee WK, Nordenskjold M: Loss of constitutional heterozygosity in human cancer. Annu Rev Genet 25: 281-314, 1991
32. Iwase H, Iwata H, Toyama T, Hara Y, Omoto Y, Ando Y, Nakamura T, Kobayashi S: The clinical value of microsatellite instability and a loss in heterozygosity in sporadic breast cancers. Breast Cancer 25: 234-238, 1997
33. Sztan M, Papai Z, Szendroi M, Looij M, Olah E: Allelic losses from chromosome 17 in human osteosarcomas. Pathol Oncol Res 3: 115-120, 1997
34. Shen C-Y, Yu J-C, Lo Y-L, Kuo C-H, Yue C-H, Jou Y-S, Huang C-S, Lung J-C, Wu C-W: Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis. Cancer Res 60: 3884-3892, 2000
35. Holt JT, Thompson ME, Szabo C, Robinson-Benion C, Arteaga CL, King MC, Jensen RA: Growth retardation and tumour inhibition by BRCA1. Nat Genet 12: 298-302, 1996
36. Seery LT, Knowlden JM, Gee JM, Robertson JF, Kenny FS, Ellis IO, Nicholson RI: BRCA1 expression levels predict distant metastasis of sporadic breast cancers. Int J Cancer 84: 258-262, 1999
37. Wilson CA, Ramos L, Villasenor MR, Anders KH, Press MF, Clarke K, Karlan B, Chen JJ, Scully R, Livingston D, Zuch RH, Kanter MH, Cohen S, Calzone FJ, Slamon DJ: Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinoma. Net Genet 21: 236-240, 1999
38. Yoshikawa K, Honda K, Inamoto T, Shinohara H, Yamauchi A, Suga K, Okuyama T, Shimada T, Kodama H, Noguchi S, Gazdar AF, Yamaoka Y, Takahashi R: Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss in BRCA1-associated cases. Clin Cancer Res 5: 1249-1261, 1999
39. Dobrovic A, Simpfendorfer D: Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res 57: 3347-3350, 1997
40. Mancini DM, Rodenhiser DI, Ainsworth PJ, O'Malley FP, Singh SM, Xing W, Archer TK: CpG methylation within the 5′ regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site. Oncogene 16: 1161-1169, 1998
41. Catteau A, Harris WH, Xu CF, Solomon E: Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene 18: 1957-1965, 1999
42. Rice JC, Futscher BW: Transcriptional repression of BRCA1 by aberrant cytosine methylation, histone hypoacetylation and chromatin condensation of the BRCA1 promoter. Nucl Acids Res 28: 3233-3239, 2000
43. Hakansson S, Johansson O, Johansson U, Sellberg G, Loman N, Gerdes A-M, Holmberg E, Dahl N, Pandis N, Kristoffersson U: Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer. Am J Hum Genet 60: 1068-1078, 1997
44. Vehmanen P, Friedman LS, Eerola H, McClure M, Ward B, Sarantaus L, Kainu T, Syrjakoski K, Pyrhonen S, Kallioniemi O-P: Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes. Hum. Mol. Genet. 6: 2309-2315, 1997
45. Buller RE, Sood AK, Lallas T, Buekers T, Skilling JS: Association between nonrandom X-chromosome inactivation and BRCA1 mutation in germline DNA of patients with ovarian cancer. J Natl Cancer Inst 91: 339-346, 1999
46. Deng G, Lu Y, Zlotnikov G, Thor AD, Smith HS: Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 274: 2057-2059, 1996
47. Kainu T, Desper R, Juo S-HH, Schaffer AA, Gillanders E, Rozenblum E, Freas-Lutz D, Weaver D, Stephan D, Bailey-Wilson J, Kallioniemi O-P, Trikkonen M, Syrjakosk K, Kuukasjarvi T, Koivisto P, Karhu R, Holli K, Arason A, Johannesdottir G, Bergthorsson JT, Johannsdottir H, Egilsson V, Barkardottir RB, Johannsson O, Haraldsson K, Sandberg T, Holmberg E, Gronberg H, Olsson H, Borg A, Vehmanen P, Eerola H, Heikkila P, Pyrhonen S, Nevanlinna H: Somatic deletion in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus. Proc Natl Acad Sci 97: 9603-9608, 2000